Table 2.
Colposcopic evaluation of patients.
| TLA (mm2) | Patients | ||||||
|---|---|---|---|---|---|---|---|
| 01 | 02 | 03 | 04 | 05 | 06 | 07 | |
| Initial | 244.93 | 493.68 | 608.98 | 638.98 | 481.71 | 30.8 | 291.96 |
| 1 month | 0 (100%) | 462.46 (6.32%) | 486.72 (20.07%) | 0 (100%) | 75.70 | 0 (100%) | 182.10 (37.62%) |
| 2 months | 0 (100%) | 441.12 (10.64%) | 381.8 (37.3%) | 0 (100%) | 48.15 | 0 (100%) | 149.78 (48.69%) |
| 3 months | 0 (100%) | 403.2 (18.32%) | 286.61 (52.93%) | 0 (100%) | 0 (100%) | 0 (100%) | 104.73 (64.12%) |
|
| |||||||
| Response status | CR | SD | PR | CR | CR | CR | PR |
Abbreviations
TLA: total lesion area.
TLA: total lesion area.
Complete response (CR) was considered as disappearance of all initial TLA; (PR) partial response if at least a 30% decrease of the initial TLA; progressive disease (PD) meant at least a 20% increase of the initial TLA and as stable disease (SD) if a reduction or an increase of the TLA compared to the initial value that is not enough for classification of the outcome as partial response or progressive disease.
%decrease = TLAinitial − TLAfinal/TLAinitial × 100.